NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.
While the unmet needs of patients in Gaza are immense, new Israeli government requirements and other restrictions are ...
Smart toilets show promise for passive monitoring of stool and urine to detect potential health issues, but challenges remain ...
Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with ...
Calling for greater regulation and transparency, Australian clinicians are objecting to what they consider to be restrictive ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
A deep molecular analysis of failing human hearts suggests diabetes may directly alter cardiac metabolism, but experts differ ...
A new integrated care pathway for paediatric acute asthma enhances inhaler use and key clinical documentation across primary ...
Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service ...
Perfectionism, empathy, and blurred boundaries — together with workload, staff shortages, and constant connectivity — create ...
Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.
They found that 1.4 years after these medications were stopped, the cardiometabolic markers that they looked at, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results